Industry experts and some opposition leaders have expressed concern over the absence of Phase 3 trial data on Covaxin.
source https://www.hindustantimes.com/india-news/bharat-biotech-vaccine-approved-in-clinical-trial-mode-consent-of-participants-has-to-be-taken-icmr/story-NSWVTh7douMtYDl1ZVnP6K.html
No comments:
Post a Comment